Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity

Patients with inborn errors of immunity (IEI) are at increased risk of severe coronavirus disease-2019 (COVID-19). Effective vaccination against COVID-19 is therefore of great importance in this group, but little is known about the immunogenicity of COVID-19 vaccines in these patients.

Gespeichert in:
Autor*in:

van Leeuwen, Leanne P.M. [verfasserIn]

GeurtsvanKessel, Corine H.

Ellerbroek, Pauline M.

de Bree, Godelieve J.

Potjewijd, Judith

Rutgers, Abraham

Jolink, Hetty

van de Veerdonk, Frank

van Gorp, Eric C.M.

de Wilt, Faye

Bogers, Susanne

Gommers, Lennert

Geers, Daryl

Bruns, Anke H.W.

Leavis, Helen L.

van Haga, Jelle W.

Lemkes, Bregtje A.

van der Veen, Annelou

de Kruijf-Bazen, S.F.J.

van Paassen, Pieter

de Leeuw, Karina

van de Ven, Annick A.J.M.

Verbeek-Menken, Petra H.

van Wengen, Annelies

Arend, Sandra M.

Ruten-Budde, Anja J.

van der Ent, Marianne W.

van Hagen, P. Martin

Sanders, Rogier W.

Grobben, Marloes

van der Straten, Karlijn

Burger, Judith A.

Poniman, Meliawati

Nierkens, Stefan

van Gils, Marit J.

de Vries, Rory D.

Dalm, Virgil A.S.H.

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2022

Schlagwörter:

CVID

SARS-CoV-2

antibody response

mRNA-1273 COVID-19 vaccine

primary immunodeficiency disorders

Inborn errors of immunity

XLA

immunogenicity

T-cell response

CID

Umfang:

9

Übergeordnetes Werk:

Enthalten in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward - Papakitsou, I. ELSEVIER, 2022, official publication of the American Academy of Allergy, Asthma and Immunology, Amsterdam [u.a.]

Übergeordnetes Werk:

volume:149 ; year:2022 ; number:6 ; pages:1949-1957 ; extent:9

Links:

Volltext

DOI / URN:

10.1016/j.jaci.2022.04.002

Katalog-ID:

ELV057933588

Nicht das Richtige dabei?

Schreiben Sie uns!